Cargando…
EGPA Phenotyping: Not Only ANCA, but Also Eosinophils
Background: Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a small-vessel necrotizing vasculitis. The anti-neutrophil cytoplasmic antibodies’ (ANCA) role in defining clinical EGPA phenotypes is well established. Although the role of eosinophils in disease pathogenesis has been clearly demon...
Autores principales: | Matucci, Andrea, Vivarelli, Emanuele, Perlato, Margherita, Mecheri, Valentina, Accinno, Matteo, Cosmi, Lorenzo, Parronchi, Paola, Rossi, Oliviero, Vultaggio, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045549/ https://www.ncbi.nlm.nih.gov/pubmed/36979755 http://dx.doi.org/10.3390/biomedicines11030776 |
Ejemplares similares
-
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience
por: Matucci, Andrea, et al.
Publicado: (2022) -
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
por: Vultaggio, Alessandra, et al.
Publicado: (2020) -
How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?
por: Vultaggio, Alessandra, et al.
Publicado: (2021) -
ANCA negative eosinophilic granulomatosis with polyangiitis (EGPA) presenting with left ventricular thrombus: An appreciation of distinct phenotypes and eosinophilic driven pathogenesis
por: Chaivannacoopt, Kai, et al.
Publicado: (2022) -
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
por: Vultaggio, Alessandra, et al.
Publicado: (2021)